A booster dose of Johnson & Johnson Inc’s single-dose COVID-19 vaccine was 84% effective at preventing hospitalization in South African healthcare workers who became infected as the omicron variant spread,…

Read more »

The post S. African Study: J&J Booster Slashes Omicron Hospitalizations appeared first on Hamodia.

In related news:

  1. Mexico Reaches One Million Virus Cases, Nears 100,000 Deaths
  2. Concerns Grow Over Eurostar Rail Linking U.K., EU
  3. U.K. Hospitals Like War Zones as COVID-19 Death Toll Approaches 100,000
  4. Johnson: UK Must Live With Virus but Restrictions can Ease
  5. English School Return Spurred COVID in Children, But Cases Fell in Adults – Study